Mira Pharmaceuticals’ IPO Fetches $9M, But Filings Spawn More Questions
Synthetic cannabinoid drug developer Mira Pharmaceuticals (Nasdaq: MIRA) secured a better-than-expected $9 million initial public
Synthetic cannabinoid drug developer Mira Pharmaceuticals (Nasdaq: MIRA) secured a better-than-expected $9 million initial public
An official with the federal Occupational Safety and Health Administration (OSHA) says that ongoing marijuana
One woman’s experience in a clinical trial on ketamine therapy turned into a real Mickey
Police in San Francisco said last week that they have already seized more narcotics this
A group of four military veterans last week filed suit against New York’s Office of
The U.S. Department of Agriculture (USDA) publishes a weekly column called “Fridays on the Farm”
By Fred Rocafort, Attorney at Harris Bricken Registering your trademarks is a critical step for
“One of the biggest problems is the lack of investment in this industry. So we
Employers are trying to bolster workplace safety as the use of marijuana rises and more
A Minnesota government psychedelics task force is being built out to prepare the state for